Joseph Jimenez

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Joseph Jimenez
NationalityAmerican
Alma materStanford University
University of California, Berkeley[1]
OccupationFormer CEO of Novartis

Joseph Jimenez is the former CEO of the Swiss pharmaceutical company Novartis.[2]

Education[edit]

Jimenez earned a bachelor's degree from Stanford University in 1982, and an MBA from University of California, Berkeley's Haas School of Business in 1984.[3]

Career[edit]

Early career[edit]

Jimenez began his career at Clorox before joining ConAgra Foods.[4][non-primary source needed] Prior to joining Novartis, he was head of H. J. Heinz Company's North American business from 2002 to 2006. He was also a non-executive director of AstraZeneca from 2002 to 2007, as well as an advisor for the Blackstone Group.[1]

Novartis[edit]

Jimenez joined Novartis in 2007 as Division Head of Novartis Pharmaceutical and was named CEO in 2010[5] by his predecessor and Chairman Daniel Vasella.[6]

During his time at Novartis, Jimenez increasingly applied standard business metrics to pharma cash flow, purchasing and competitive bidding, confident that his experience in consumer goods would help to realize improvements in Novartis' operations. His cost-cutting moves, focused mostly on marketing and administration, came steadily, with more than a billion cut in 2010, and even more than that in 2011.[7]

Jimenez joined the Board of Directors at General Motors on June 9, 2015[8]

Jimenez resigned from Novartis, leaving in February 2018, and was succeeded by Vasant Narasimhan.[9]

He joined the Board of Directors of San Francisco biotech startup uBiome in September 2018[10] and stepped down in April 2019 to run his own venture fund.[11][12][13][14]

References[edit]

  1. ^ a b http://www.novartisfoundation.org/platform/content/element/4381/bio_jimenez_e_final.pdf
  2. ^ "Fix the Problem, and Not Just the Symptoms". New York Times. Retrieved 22 May 2013.
  3. ^ "Joseph Jimenez MBA". Businessweek. Retrieved 22 May 2013.
  4. ^ "Joseph Jimenez - Forbes". People.forbes.com. 2012-04-18. Retrieved 2012-08-02.
  5. ^ "Joseph Jimenez - The 25 most influential people in biopharma today". Fierce Biotech. Retrieved 22 May 2013.
  6. ^ Greil, Anita (2010-01-26). "Vasella's Impeccable Timing - The Source - WSJ". Blogs.wsj.com. Retrieved 2012-08-02.
  7. ^ "Joseph Jimenez - The 25 most influential people in biopharma today - FierceBiotech". www.fiercebiotech.com.
  8. ^ http://www.gm.com/company/aboutGM/board_of_directors0/joseph_jimenez.html. Missing or empty |title= (help)[permanent dead link]
  9. ^ "Novartis CEO Jimenez to Quit, Giving Reins to Harvard Doctor". Bloomberg.com. Bloomberg Technology. 4 September 2017. Retrieved 5 September 2017.
  10. ^ "Why former Novartis CEO Joe Jimenez joined a microbiome startup board".
  11. ^ Ramsey, Lydia (May 17, 2019). "Dispensed: How health insurance startups fared at the start of 2019, Impossible Foods' big burger change, and a look at uBiome's board".
  12. ^ "UBiome's independent directors are dropping the health care start-up following an FBI raid, and now there's just 1 left". May 15, 2019.
  13. ^ "UBiome's Independent Directors are Ditching the Healthcare Startup Following an FBI Raid". May 15, 2019.
  14. ^ Ramsey, Lydia (May 15, 2019). "uBiome's independent directors are ditching the healthcare startup following an FBI raid, and now there's only 1 left".

External links[edit]